Compare $ALLR vs $DYAI | Chartloom

Compare

$ALLR vs $DYAI

Allarity Therapeutics Inc · Dyadic International Inc

ALLR

Allarity Therapeutics Inc

DYAI

Dyadic International Inc

Compare $ALLR vs $DYAI

Comparing Allarity Therapeutics Inc and Dyadic International Inc

ALLRAllarity Therapeutics Inc

DYAIDyadic International Inc

ALLRAllarity Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-13.2%

52W performance

-41.8%

FCF yield

-87.5%

DYAIDyadic International Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.15x

Rev growth (TTM)

-8.1%

YTD performance

-52.8%

52W performance

-60.7%

FCF yield

-45.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALLR

DYAI

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

DYAI

Dyadic International Inc

Market Cap

ALLR$16M

DYAI$16M

Enterprise Value

ALLR$21M

DYAI$20M

Price

ALLR$0.99

DYAI$0.44

P/E Ratio

ALLRN/A

DYAIN/A

P/S Ratio

ALLR45.65x

DYAI4.26x

EV/Sales

ALLR61.03x

DYAI5.21x

EV/EBITDA

ALLR0.00x

DYAI75.44x

P/B Ratio

ALLR4.68x

DYAI14.82x

P/FCF Ratio

ALLRN/A

DYAIN/A

EV/FCF

ALLR-1.53x

DYAI-2.67x

PEG Ratio

ALLRN/A

DYAIN/A

Forward P/E (NTM)

ALLRN/A

DYAIN/A

Forward P/S (NTM)

ALLRN/A

DYAI2.15x

Revenue (TTM)

ALLR$345K

DYAI$4M

Revenue Growth (YoY)

ALLRN/A

DYAI-8.1%

Forward Rev Growth

ALLR0.0%

DYAI91.1%

Gross Margin (TTM)

ALLR0.0%

DYAI16.2%

Operating Margin (TTM)

ALLR0.0%

DYAI0.0%

EBITDA Margin (TTM)

ALLR-771.9%

DYAI-194.5%

Net Margin (TTM)

ALLR-3575.1%

DYAI-200.5%

FCF Margin (TTM)

ALLR-3994.8%

DYAI-194.7%

Net Income (TTM)

ALLR$-12M

DYAI$-8M

FCF (TTM)

ALLR$-14M

DYAI$-7M

EPS (TTM)

ALLR-$0.78

DYAI-$0.21

ROE (TTM)

ALLR-15277.0%

DYAI-35086.0%

ROA (TTM)

ALLR-4650.0%

DYAI-8477.0%

ROIC (TTM)

ALLR-6256.0%

DYAI-8444.0%

Cash

ALLR$17M

DYAI$1M

Debt

ALLR$22M

DYAI$5M

Net Cash/Debt

ALLR$-5M

DYAI$-4M

Current Ratio (TTM)

ALLR1.11x

DYAI1.65x

Quick Ratio (TTM)

ALLR0.99x

DYAI1.54x

Debt/Equity (TTM)

ALLR6.30x

DYAI4.08x

Debt/Assets (TTM)

ALLR0.0%

DYAI0.0%

Interest Coverage (TTM)

ALLRN/A

DYAIN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

DYAI0.00x

Beta

ALLR0.60

DYAI1.09

52W Performance

ALLR-41.8%

DYAI-60.7%

YTD Performance

ALLR-13.2%

DYAI-52.8%

% from 52W High

ALLR-46.2%

DYAI-72.2%

% from 52W Low

ALLR28.6%

DYAI30.6%

Asset Turnover (TTM)

ALLR0.00x

DYAI0.42x

FCF Yield (TTM)

ALLR-87.5%

DYAI-45.8%

Earnings Yield (TTM)

ALLR-78.3%

DYAI-47.1%

Dividend Yield (TTM)

ALLRN/A

DYAIN/A

Rule of 40

ALLR-3,994.8

DYAI-202.8

EV/GP/RG

ALLRN/A

DYAI0.30

Ticker research

View ALLR research View DYAI research

Metric	ALLR Allarity Therapeutics Inc	DYAI Dyadic International Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$21M	$20M
Price	$0.99	$0.44
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	4.26x
EV/Sales	61.03x	5.21x
EV/EBITDA	0.00x	75.44x
P/B Ratio	4.68x	14.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	-2.67x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.15x
Revenue & Growth
Revenue (TTM)	$345K	$4M
Revenue Growth (YoY)	N/A	-8.1%
Forward Rev Growth	0.0%	91.1%
Profitability
Gross Margin (TTM)	0.0%	16.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	-194.5%
Net Margin (TTM)	-3575.1%	-200.5%
FCF Margin (TTM)	-3994.8%	-194.7%
Net Income (TTM)	$-12M	$-8M
FCF (TTM)	$-14M	$-7M
EPS (TTM)	-$0.78	-$0.21
ROE (TTM)	-15277.0%	-35086.0%
ROA (TTM)	-4650.0%	-8477.0%
ROIC (TTM)	-6256.0%	-8444.0%
Financial Health
Cash	$17M	$1M
Debt	$22M	$5M
Net Cash/Debt	$-5M	$-4M
Current Ratio (TTM)	1.11x	1.65x
Quick Ratio (TTM)	0.99x	1.54x
Debt/Equity (TTM)	6.30x	4.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.09
52W Performance	-41.8%	-60.7%
YTD Performance	-13.2%	-52.8%
% from 52W High	-46.2%	-72.2%
% from 52W Low	28.6%	30.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.42x
FCF Yield (TTM)	-87.5%	-45.8%
Earnings Yield (TTM)	-78.3%	-47.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	-202.8
EV/GP/RG	N/A	0.30
Ticker research	View ALLR research	View DYAI research

Valuation

P/S Ratio

DYAI

4.26x

ALLR

45.65x

EV/FCF

DYAI

-2.67x

ALLR

-1.53x

Growth & revenue

Revenue Growth TTM

DYAI

-8.1%

Forward Revenue Growth

DYAI

91.1%

ALLR

0.0%

Profitability & performance

Gross Margin

DYAI

16.2%

ALLR

0.0%

ROE

ALLR

-15277.0%

DYAI

-35086.0%

FCF Yield %

DYAI

-45.8%

ALLR

-87.5%

52-Week Performance

ALLR

-41.8%

DYAI

-60.7%

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

DYAI

Dyadic International Inc

Market Cap

ALLR$16M

DYAI$16M

Enterprise Value

ALLR$21M

DYAI$20M

Price

ALLR$0.99

DYAI$0.44

P/E Ratio

ALLRN/A

DYAIN/A

P/S Ratio

ALLR45.65x

DYAI4.26x

EV/Sales

ALLR61.03x

DYAI5.21x

EV/EBITDA

ALLR0.00x

DYAI75.44x

P/B Ratio

ALLR4.68x

DYAI14.82x

P/FCF Ratio

ALLRN/A

DYAIN/A

EV/FCF

ALLR-1.53x

DYAI-2.67x

PEG Ratio

ALLRN/A

DYAIN/A

Forward P/E (NTM)

ALLRN/A

DYAIN/A

Forward P/S (NTM)

ALLRN/A

DYAI2.15x

Revenue (TTM)

ALLR$345K

DYAI$4M

Revenue Growth (YoY)

ALLRN/A

DYAI-8.1%

Forward Rev Growth

ALLR0.0%

DYAI91.1%

Gross Margin (TTM)

ALLR0.0%

DYAI16.2%

Operating Margin (TTM)

ALLR0.0%

DYAI0.0%

EBITDA Margin (TTM)

ALLR-771.9%

DYAI-194.5%

Net Margin (TTM)

ALLR-3575.1%

DYAI-200.5%

FCF Margin (TTM)

ALLR-3994.8%

DYAI-194.7%

Net Income (TTM)

ALLR$-12M

DYAI$-8M

FCF (TTM)

ALLR$-14M

DYAI$-7M

EPS (TTM)

ALLR-$0.78

DYAI-$0.21

ROE (TTM)

ALLR-15277.0%

DYAI-35086.0%

ROA (TTM)

ALLR-4650.0%

DYAI-8477.0%

ROIC (TTM)

ALLR-6256.0%

DYAI-8444.0%

Cash

ALLR$17M

DYAI$1M

Debt

ALLR$22M

DYAI$5M

Net Cash/Debt

ALLR$-5M

DYAI$-4M

Current Ratio (TTM)

ALLR1.11x

DYAI1.65x

Quick Ratio (TTM)

ALLR0.99x

DYAI1.54x

Debt/Equity (TTM)

ALLR6.30x

DYAI4.08x

Debt/Assets (TTM)

ALLR0.0%

DYAI0.0%

Interest Coverage (TTM)

ALLRN/A

DYAIN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

DYAI0.00x

Beta

ALLR0.60

DYAI1.09

52W Performance

ALLR-41.8%

DYAI-60.7%

YTD Performance

ALLR-13.2%

DYAI-52.8%

% from 52W High

ALLR-46.2%

DYAI-72.2%

% from 52W Low

ALLR28.6%

DYAI30.6%

Asset Turnover (TTM)

ALLR0.00x

DYAI0.42x

FCF Yield (TTM)

ALLR-87.5%

DYAI-45.8%

Earnings Yield (TTM)

ALLR-78.3%

DYAI-47.1%

Dividend Yield (TTM)

ALLRN/A

DYAIN/A

Rule of 40

ALLR-3,994.8

DYAI-202.8

EV/GP/RG

ALLRN/A

DYAI0.30

Ticker research

View ALLR research View DYAI research

Metric	ALLR Allarity Therapeutics Inc	DYAI Dyadic International Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$21M	$20M
Price	$0.99	$0.44
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	4.26x
EV/Sales	61.03x	5.21x
EV/EBITDA	0.00x	75.44x
P/B Ratio	4.68x	14.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	-2.67x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.15x
Revenue & Growth
Revenue (TTM)	$345K	$4M
Revenue Growth (YoY)	N/A	-8.1%
Forward Rev Growth	0.0%	91.1%
Profitability
Gross Margin (TTM)	0.0%	16.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	-194.5%
Net Margin (TTM)	-3575.1%	-200.5%
FCF Margin (TTM)	-3994.8%	-194.7%
Net Income (TTM)	$-12M	$-8M
FCF (TTM)	$-14M	$-7M
EPS (TTM)	-$0.78	-$0.21
ROE (TTM)	-15277.0%	-35086.0%
ROA (TTM)	-4650.0%	-8477.0%
ROIC (TTM)	-6256.0%	-8444.0%
Financial Health
Cash	$17M	$1M
Debt	$22M	$5M
Net Cash/Debt	$-5M	$-4M
Current Ratio (TTM)	1.11x	1.65x
Quick Ratio (TTM)	0.99x	1.54x
Debt/Equity (TTM)	6.30x	4.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.09
52W Performance	-41.8%	-60.7%
YTD Performance	-13.2%	-52.8%
% from 52W High	-46.2%	-72.2%
% from 52W Low	28.6%	30.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.42x
FCF Yield (TTM)	-87.5%	-45.8%
Earnings Yield (TTM)	-78.3%	-47.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	-202.8
EV/GP/RG	N/A	0.30
Ticker research	View ALLR research	View DYAI research